← FDA Drug Approvals (Drugs@FDA)

HALOPERIDOL DECANOATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2023-05-23

Drug application

FDA Application #
ANDA216730
Application type
Abbreviated New Drug Application (Generic)
Brand name
HALOPERIDOL DECANOATE
Generic name
HALOPERIDOL DECANOATE
Active ingredients
HALOPERIDOL DECANOATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
MANKIND PHARMA
Manufacturer
NorthStar RxLLC
First approval
2023-05-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown